Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). (Q44047912)
Jump to navigation
Jump to search
scientific article published in July 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). |
scientific article published in July 2002 |
Statements
1 reference
Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT). (English)
1 reference
1 reference
Fischer T
1 reference
Reifenrath C
1 reference
Hess GR
1 reference
Corsetti MT
1 reference
Kreil S
1 reference
Beck J
1 reference
Meinhardt P
1 reference
Beltrami G
1 reference
Schuch B
1 reference
Gschaidmeier H
1 reference
Hehlmann R
1 reference
Carella A
1 reference
Huber C
1 reference
1 July 2002
1 reference
1 reference
16
1 reference
7
1 reference
1220-1228
1 reference
Identifiers
1 reference
1 reference